Regulatory PathRegulatory requirements compared

Active substance

Gonadorelin

Open in the medicines table

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
FACTRELEQ 0.1MG BASE/VIAL; EQ 0.2MG BASE/VIAL; EQ 0.5MG BASE/VIALinjectable · injectionHIKMA PHARMSDiscontinued30 Sep 1982
LUTREPULSE KIT0.8MG/VIAL; 3.2MG/VIALinjectable · injectionFERRINGDiscontinued10 Oct 1989

UK MHRA United Kingdom — marketing authorisations

ProductAuthorisationHolderLegal status
GONADORELIN 100 MICROGRAMS POWDER FOR SOLUTION FOR INJECTIONPL 17509/0005ESTEVE PHARMACEUTICALS LTDPOM
HRF 100MCG (POWDER FOR RECONSTITUTION FOR INJECTION)PL 17509/0005ESTEVE PHARMACEUTICALS LTDPOM

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.